The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients

BACKGROUND: HAART has improved survival of HIV patients. Its contribution to the development of new cardiovascular abnormalities has generated much interest. This study aimed at determining the prevalence of QTc prolongation among HIV patients and determining the influence if any of the use of HAART...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogunmodede, James, Kolo, Philip, Katibi, Ibraheem, Omotoso, Ayodele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Publications Office of Jimma University 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811940/
https://www.ncbi.nlm.nih.gov/pubmed/29487470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811940/
https://www.ncbi.nlm.nih.gov/pubmed/29487470

Ejemplares similares